Additional Content Download

As the serialisation industry prepares for various approaching deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide track and trace compliance strategies.

Christoph Krahenbuhl, IS Programme Manager for Pack Coding and Product Security at AstraZeneca, talks to Helen Winsor from Pharma IQ about the challenges associated with pharmaceutical serialisation and traceability and how they are being addressed.

Sebastien Mauel, Head of Product Security, Merck Serono, shares his insights with Pharma IQ at IQPC's Pharmaceutical Serialisation & Traceability event. Mauel discusses the current challenges relating to detecting counterfeit drugs in the supply chain, preventing counterfeiting at the pharmacy, strategies for successful authentication of pharmaceutical products and the benefits and pitfalls of the e-pedigree approach.

Pharma IQ presents this interactive one page guide to the Drug Supply Chain Security Act (DSCSA) Implementation Plan

After around six months of consultation, global standards organisation GS1 is in the final stages of compiling its Brazilian Medicine Traceability using GS1 EPCIS Part 1 Implementation Guide.

In the lead up to this hotly anticipated document, Pharma IQ spoke to Eduardo Salles, Director da Dotter do Brazil who assisted with the creation of this GS1 file.

In this article we will discuss publishing the related serialisation information and two of the common serialisation models, Authentication and Track and Trace. Product Information Notification Typically, once product packaging of one or more levels has been uniquely identified, this information, together with other information related to the product and manufacturer is passed to an external agency database. 

In this Pharma IQ interview Pasi Kemppainen, executive consultant for serialisation and traceability and current lead of serialisation implementation at Orion Pharma, shares his insights on why the pharmaceutical industry has been slow to adopt mass serialisation, key implementation challenges and preparing for regulation requirements in the future.

In this presentation Christoph Krähenbühl, IS Programme Manager, Pack Coding and Product Security, AstraZeneca discusses product security, patient safety, anti-counterfeiting, supply chain control and coding. He also discussed how AstraZeneca tackles some of these issues.

As counterfeit drug sales become increasingly costly to both pharmaceutical manufacturers and patients, companies are attempting to address the challenges of serialisation and traceability to reduce the burden on health services across the world.

Pasi Kemppainen is an executive consultant for serialisation and traceability and currently leading the serialisation implementation at Orion Pharma. In this interview he speaks to Andrea Charles from Pharma IQ, about managing and implementing serialisation and shares his top tip for preparing  for regulation requirements and implementation in the future. 

The American Government's Drug Quality and Security Act will have a big impact on pharma.  

In response to popular demand, Pharma IQ is proud to announce the launch of their definitive buyers guide to serialisation and traceability. This handy guide will feature all the major solution providers in the solutions space able to comply with the new complex regulations and provide insight into what their unqique offerings are.

Pharma IQ spoke to Mark Davison, Chief Executive Officer at Blue Sphere Health Ltd to gain insight on his experience working with SME pharma & biotechs for serialisation. Also we spoke to Vetter pharma – a responsible CMO for their insight on how peer CMOs optimise their serialisation strategy.

This year’s research report maps out and measures the changes in consensus as the industry advances closer to an entirely track and traced pharmaceutical environment.

Download to view the results of the 2016 report. 

No matter where you are in your serialisation journey the 7th Annual Pharmaceutical Serialisation & Traceability Summit has all the information you need. Topics ranging from early implementation all the way to implementing your level 4 communication strategy.

Pharma IQ spoke to Jean Marc Bobee of Sanofi to find out about what’s next for the market in terms of serialisation.

Pharma IQ spoke to Jay Jay Han of Hanmi Pharmaceutical to explore the serialisation landscape in South Korea.

Pharma IQ talks to some of the attendees at Serialisation & Traceability 2015 to gain their thoughts on the conference

In the absence of a one-size-fits all-approach, after consulting with industry experts, Pharma IQ proposes this framework for key milestones within a sustainable serialisation strategy - in which firms can choose customize in relevance to their requirements.

Roger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone.

Undoubtedly, technology stands as a keystone in a controlled track and trace system.

In this eBook we look at the key considerations organisations face in finding the right technologies and focus on the strategies for integration to ensure a successful serialisation project.


 

The global pharmaceutical industry is moving towards a serialised world. In over 40 countries, regulatory mandates to secure the supply chain are already in place or in development. We have created this printable map to provide an overview of various nations’ progress in their serialisation journey.